ANN ARBOR, Mich., May 14, 2012 /PRNewswire-USNewswire/ -- The Michigan Venture Capital Association (MVCA) recently released its annual research report, which details investment activity across

LUXEMBOURG, May 3, 2012 /PRNewswire/ -- Creabilis SA, a European biotechnology company specialising in the development of treatments for dermatology, inflammation and pain,

OXFORD, England, April 25, 2012 /PRNewswire/ -- The rise of the corporate venture fund and the landscape for early-stage venture capital investing are emerging key themes

SALT LAKE CITY, March 28, 2012 /PRNewswire/ -- Signal Peak Ventures and vSpring Capital, two leading venture capital firms in the Rocky Mountain region, today announced the combination of

MINNEAPOLIS, MN, Feb. 22, 2012 /PRNewswire/ - BioAmber Inc. has completed its Series C round of financing with net proceeds of $30 million.